Heron Therapeutics reported $8.38M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
ALKERMES USD 107.69M 35.17M Sep/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
Amarin USD 40.43M 21.63M Sep/2026
ANI Pharmaceuticals USD 74.41M 585K Sep/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 30.15M 2.37M Sep/2026
Eisai JPY 81.67B 5.86B Sep/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Heron Therapeutics USD 8.38M 3.27M Sep/2026
Insmed USD 84.3M 9.75M Sep/2026
Ligand Pharmaceuticals USD 4.1M 5.31M Sep/2026
Merck USD 5.03B 1.2B Sep/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 754.1M 612.1M Sep/2026
Omeros USD 8.84M 4.42M Jun/2025
Regeneron Pharmaceuticals USD 1.14B 19M Sep/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Ultragenyx Pharmaceutical USD 45M 6M Sep/2026
Veracyte USD 9.71M 1.69M Sep/2026
Vertex Pharmaceuticals USD 3.71B 99.2M Sep/2026